Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Financial Ratios
Welcure Drugs & Pharmaceuticals Ltd.
BSE Code 524661
ISIN Demat INE331C01017
Book Value (Rs) 1.06
NSE Code NA
Dividend Yield % 0.00
Market Cap(Rs Mn) 69.59
TTM PE(x) 632.61
TTM EPS(Rs) 0.01
Face Value (Rs) 10  
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)0.08  0.02  0.05  -0.01  0.00  
   CEPS(Rs)0.08  0.02  0.05  -0.01  0.00  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)1.13  0.08  0.06  0.01  0.02  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)0  22.52  41.26  -11.64  2.91  
   EBIT Margin(%)0  22.52  41.42  -11.27  4.99  
   Pre Tax Margin(%)0  22.46  41.36  -11.39  4.88  
   PAT Margin (%)0  22.46  41.36  -11.39  4.88  
   Cash Profit Margin (%)0  22.46  41.36  -11.39  4.88  
Performance Ratios          
   ROA(%)12.51  27.77  112.99  -34.54  14.57  
   ROE(%)12.65  29.03  131.74  -49.46  17.83  
   ROCE(%)12.67  29.12  131.94  -48.94  18.22  
   Asset Turnover(x)0.00  1.24  2.73  3.03  2.99  
   Sales/Fixed Asset(x)0.00  0  0  0  0  
   Working Capital/Sales(x)0.00  1.69  1.92  5.77  3.35  
Efficiency Ratios          
   Fixed Capital/Sales(x)0  0.00  0.00  0.00  0.00  
   Receivable days0  0.00  0.00  0.00  0.00  
   Inventory Days0  0.00  0.00  0.00  0.00  
   Payable days0  0  0  0  0  
Valuation Parameters          
   PER(x)53.10  501.03  41.32  0.00  165.62  
   PCE(x)51.48  502.13  41.31  -51.57  165.62  
   Price/Book(x)3.57  127.31  32.82  33.90  27.09  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)0  112.13  16.73  5.81  7.89  
   EV/Core EBITDA(x)51.40  497.89  40.39  -51.55  158.27  
   EV/EBIT(x)53.02  497.89  40.39  -51.55  158.27  
   EV/CE(x)3.53  121.61  30.55  19.49  21.03  
   M Cap / Sales0  112.76  17.09  5.88  8.08  
Growth Ratio          
   Net Sales Growth(%)-100.00  -21.26  61.63  3.77  59.00  
   Core EBITDA Growth(%)344.39  -57.19  693.92  -334.64  120.54  
   EBIT Growth(%)330.78  -57.19  693.92  -334.64  120.54  
   PAT Growth(%)331.41  -57.24  686.68  -342.39  119.99  
   EPS Growth(%)288.21  -57.14  683.33  -343.74  120.00  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)0.43  17.30  20.33  2.39  4.88  
   Quick Ratio(x)0.43  17.30  20.33  2.39  4.88  
   Interest Cover(x)703.02  346.74  636.34  -93.00  46.36  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00